Pierre Charles

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Pierre Charles, Benjamin Terrier, Élodie Perrodeau et al. · Annals of the Rheumatic Diseases · 2018 · 325 citations

Single-Center Trials Show Larger Treatment Effects Than Multicenter Trials: Evidence From a Meta-epidemiologic Study

Agnès Dechartres, Isabelle Boutron, Ludovic Trinquart et al. · Annals of Internal Medicine · 2011 · 314 citations

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

Misrepresentation of Randomized Controlled Trials in Press Releases and News Coverage: A Cohort Study

Amélie Yavchitz, Isabelle Boutron, Aïda Bafeta et al. · PLoS Medicine · 2012 · 270 citations · Full text

Different phenotypes in dermatomyositis associated with anti-MDA5 antibody

Yves Allenbach, Y. Uzunhan, S. Toquet et al. · Neurology · 2020 · 229 citations · Full text